TA805314 uPA / PLAU antibody

PLAU mouse monoclonal antibody, clone OTI1D4 (formerly 1D4)

See related secondary antibodies

Search for all "uPA / PLAU"

0.1 ml / €350.00
Please visit the country specific website of OriGene Technologies or contact your local Distributor to buy this product.

TrueMAB

Quick Overview

Mouse anti Human uPA / PLAU OTI1D4

Product Description for uPA / PLAU

Mouse anti Human uPA / PLAU OTI1D4.
Presentation: Purified
Product is tested for Western blot / Immunoblot.

Properties for uPA / PLAU

Product Category Primary Antibodies
Target Category
Quantity 0.1 ml
Synonyms U-plasminogen activator, Urokinase, Urokinase-type plasminogen activator, Urokinase-type plasminogen activator chain B, Urokinase-type plasminogen activator long chain A, Urokinase-type plasminogen activator short chain A
Presentation Purified
Reactivity Hu
Applications WB
Clonality Monoclonal
Clone OTI1D4
Host Mouse
Isotype IgG1
Shipping to Europe, USA/Canada
PDF datasheet View Datasheet
Manufacturer OriGene Technologies, Inc.

Datasheet Extract

Immunogen
Swiss Prot Num:
P00749
Immunogen:
Human recombinant protein fragment corresponding to amino acids 107-379 of human PLAU (NP_002649) produced in E.coli.
GeneID:
5328
Isotype control AM03095PU-N, SM10P (for use in human samples)
Application WB 1:200
Background This gene encodes a serine protease involved in degradation of the extracellular matrix and possibly tumor cell migration and proliferation. A specific polymorphism in this gene may be associated with late-onset Alzheimer's disease and also with decreased affinity for fibrin-binding. This protein converts plasminogen to plasmin by specific cleavage of an Arg-Val bond in plasminogen. Plasmin in turn cleaves this protein at a Lys-Ile bond to form a two-chain derivative in which a single disulfide bond connects the amino-termil A-chain to the catalytically active, carboxy-termil B-chain. This two-chain derivative is also called HMW-uPA (high molecular weight uPA). HMW-uPA can be further processed into LMW-uPA (low molecular weight uPA) by cleavage of chain A into a short chain A (A1) and an amino-termil fragment. LMW-uPA is proteolytically active but does not bind to the uPA receptor. Altertively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Feb 2009].
Format
Purification:
Purified from mouse ascites fluids by affinity chromatography
Buffer System:
PBS (PH 7.3) containing 1% BSA, 50% glycerol and 0.02% sodium azide.
State:
Purified

Accessory Products

Proteins and/or Positive Controls

Proteins for uPA / PLAU (16 products)

Catalog No. Species Pres. Purity   Source  

uPA / PLAU (transcript variant 1)

uPA / PLAU Human > 80 %
Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps.
Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining.
HEK293 cells
20 µg / €680.00
  OriGene Technologies, Inc.

uPA / PLAU (transcript variant 1)

uPA / PLAU Human > 95 %
Preparation: .
Purity Detail: >95% as determined by SDS-PAGE and Coomassie blue staining.
HEK293 cells
10 µg / €210.00
  OriGene Technologies, Inc.

uPA / PLAU (HMW)

uPA / PLAU Human Purified >98% pure (SDS-PAGE). 95% high molecular weight. Purified by column chromatography Urine
  OriGene Technologies GmbH

uPA / PLAU (LMW Isoform)

uPA / PLAU Human Purified >98% pure (SDS-PAGE). >98% low molecular weight. Column chromatography Urine
  OriGene Technologies GmbH

uPA / PLAU

uPA / PLAU Human Purified > 90.0% as determined by SDS-PAGE. 
Contaminents: Free of: Hepatitis B surface antigen, Hepatitis C antibody and HIV I and II.
  OriGene Technologies GmbH

uPA / PLAU

uPA / PLAU Human Purified > 90.0% as determined by SDS-PAGE. 
Contaminents: Free of: Hepatitis B surface antigen, Hepatitis C antibody and HIV I and II.
  OriGene Technologies GmbH

uPA / PLAU

uPA / PLAU Human Purified > 90.0% as determined by SDS-PAGE. 
Contaminents: Free of: Hepatitis B surface antigen, Hepatitis C antibody and HIV I and II.
  OriGene Technologies GmbH

uPA / PLAU

uPA / PLAU Human Purified > 90 % Free of Hepatitis B surface antigen, Hepatitis C antibody and HIV I and II.
Purity is greater than 90.0% as determined by SDS-PAGE.
Urine
  OriGene Technologies GmbH

uPA / PLAU

uPA / PLAU Human Purified > 90 % Free of Hepatitis B surface antigen, Hepatitis C antibody and HIV I and II.
Purity is greater than 90.0% as determined by SDS-PAGE.
Urine
  OriGene Technologies GmbH

uPA / PLAU

uPA / PLAU Human Purified > 90 % Free of Hepatitis B surface antigen, Hepatitis C antibody and HIV I and II.
Purity is greater than 90.0% as determined by SDS-PAGE.
Urine
  OriGene Technologies GmbH

uPA / PLAU

uPA / PLAU Human 12.5% SDS-PAGE Stained with Coomassie Blue. in vitro transl.
  Abnova Taiwan Corp.

uPA / PLAU

uPA / PLAU Human 12.5% SDS-PAGE Stained with Coomassie Blue. in vitro transl.
  Abnova Taiwan Corp.

uPA / PLAU

uPA / PLAU Human
  Abnova Taiwan Corp.

uPA / PLAU

uPA / PLAU Human
  Abnova Taiwan Corp.

uPA / PLAU

uPA / PLAU Human
  Abnova Taiwan Corp.

uPA / PLAU

uPA / PLAU Human
  Abnova Taiwan Corp.

Positive controls for uPA / PLAU (1 products)

Catalog No. Species Pres. Purity   Source  

Urokinase Lysate

Western Blot: Urokinase Lysate [NBL1-14486] - Western Blot experiments. 
Left-Control; Right -Over-expression Lysate for PLAU
  Novus Biologicals Inc.
  • LinkedIn